A targeted isotope dilution mass spectrometry assay for osteopontin quantification in plasma of metastatic breast cancer patients

• Andrew Leslie,

  Roles Investigation, Methodology, Writing – original draft, Writing – review & editing

  Affiliation Human Health Therapeutics Research Center, National Research Council, Halifax, Nova Scotia, United Kingdom

  ⨯
• Evelyn Teh,

  Roles Investigation, Project administration, Resources, Writing – review & editing

  Affiliation Human Health Therapeutics Research Center, National Research Council, Halifax, Nova Scotia, United Kingdom

  ⨯
• Arik Druker,

  Roles Funding acquisition, Project administration, Supervision, Writing – review & editing

  Affiliations Nova Scotia Health Authority, Division of Medical Oncology, Halifax, Nova Scotia, United Kingdom, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, United Kingdom

  ⨯
• Devanand M. Pinto

  Roles Conceptualization, Funding acquisition, Investigation, Writing – original draft, Writing – review & editing

  * E-mail: dev.pinto@nrc.ca

  Affiliations Human Health Therapeutics Research Center, National Research Council, Halifax, Nova Scotia, United Kingdom, Department of Chemistry, Dalhousie University, Halifax, Nova Scotia, United Kingdom

  https://orcid.org/0000-0002-0665-7041

  ⨯